4.6 Review

The Roles of Lpar1 in Central Nervous System Disorders and Diseases

Journal

FRONTIERS IN NEUROSCIENCE
Volume 15, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnins.2021.710473

Keywords

Lpar1; Edg2; astroglia; microglia; oligodendrocyte; astrocyte

Categories

Funding

  1. National Natural Science Foundation of China [82001593, 81971433, 82071353, 81771634, 81971428]
  2. Key R&D Projects of Science and Technology Department of Sichuan Province [2021YFS0029, 2020YFS0104]

Ask authors/readers for more resources

Lpar1 is a widely distributed receptor in human tissues and most abundant in the brain, with its protein encoded by Edg2 present in various cell types in the CNS. Deletion of Lpar1 can lead to neurodevelopmental disorders and a variety of CNS diseases, making Lpar1/Edg2 a potential therapeutic target for CNS disorders and diseases.
Lysophosphatidic acid receptor 1 (Lpar1), which is found in almost all human tissues but is most abundant in the brain, can couple to G protein-coupled receptors (GPCRs) and participate in regulating cell proliferation, migration, survival, and apoptosis. Endothelial differentiation gene-2 receptor (Edg2), the protein encoded by the Lpar1 gene, is present on various cell types in the central nervous system (CNS), such as neural stem cells (NSCs), oligodendrocytes, neurons, astrocytes, and microglia. Lpar1 deletion causes neurodevelopmental disorders and CNS diseases, such as brain cancer, neuropsychiatric disorders, demyelination diseases, and neuropathic pain. Here, we summarize the possible roles and mechanisms of Lpar1/Edg2 in CNS disorders and diseases and propose that Lpar1/Edg2 might be a potential therapeutic target for CNS disorders and diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available